GleamWall
中文EN

SNDL SNDL Inc. IFRS Annual reports only

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1766600 · Reporting currency CAD · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY2.8%
TTM net income YoY83.4%
TTM EPS YoY83.3%
Revenue 3-yr CAGR9.9%
Net income 3-yr CAGR—

Margins

Gross margin27.3%
Operating margin-0.7%
Net margin-1.7%
FCF margin6.1%
EBITDA margin4.8%

Returns

ROE-1.4%
ROA-1.2%
ROIC (approx.)-0.6%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets17.6%
Debt / equity0.00x
Current ratio4.88x
Interest coverage-0.95x

Cash quality & payout

Operating cash flow / net income-4.50x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY20252025-12-31FY20242024-12-31
Income statement
Revenue946.40M920.45M
Cost of revenue687.75M680.12M
Gross profit258.65M240.33M
R&D expense489,000346,000
SG&A expense182.16M187.24M
Operating income-6.35M-103.81M
Interest expense6.69M7.16M
Pretax income-15.77M-105.61M
Net income-15.77M-94.80M
EBITDA45.60M-49.56M
EPS (basic)-0.06-0.36
EPS (diluted)-0.06-0.36
Balance sheet
Cash & equivalents252.24M218.36M
Short-term investments484,00027.56M
Receivables24.10M24.55M
Inventory126.88M127.92M
Current assets449.62M461.84M
PP&E, netmay include right-of-use assets (IFRS)151.90M145.81M
Goodwill124.25M124.25M
Intangibles58.52M61.33M
Total assets1.34B1.35B
Current liabilities92.21M90.56M
Total liabilities234.72M215.89M
Shareholders' equity1.10B1.13B
Cash flow statement
Operating cash flow70.92M54.91M
Capital expenditure12.81M8.62M
Free cash flow58.11M46.30M
Investing cash flow17.45M17.76M
Financing cash flow-54.49M-49.36M
Depreciation & amortization51.95M54.25M
Stock-based compensation13.90M20.04M
Share buybacks15.35M13.22M

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.